CompletedPhase 4

Flurbiprofen Axetil for Uterine Contraction Pain

China97 participantsStarted 2008-05

Plain-language summary

Uterine contraction pain is a common problem after abortion. Optimal analgesic for such suffering is still needed to be guaranteed. Flurbiprofen Axetil is a target-distributable non-steroidal anti-inflammatory drug (NSAID) functioning via block the synthesis of prostaglandin E (PGE). The investigators hypothesized that Flurbiprofen Axetil could suppress the uterine contraction pain after abortion effectively.

Who can participate

Age range19 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ASA status I-II * Performing abortion operation (medical- or drug-induced * Requiring painless abortion Exclusion Criteria: * \< 19yrs, and \>= 45yrs * History of central active drugs administration * Drug abuse * Hypertension * Diabetes * Any other chronic diseases * Allergy to the study drugs * Habit of over-volume alcohol drinking * Records of history of centrally active drug use and psychiatry * Any organic disorders

What they're measuring

VAS pain scorings

Timeframe: At the end of the operation, 0,5,15,30,60min after operation

Trial details

NCT IDNCT00725218

SponsorNanjing Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-08

View on ClinicalTrials.gov More Postoperative Pain trials